 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Medicine > Isis Pharmaceuticals, Inc.
 |
Isis Pharmaceuticals, Inc. |
 |
 |
 |
NEWS FROM THE WIRES |
 |
Lilly, Isis in reseach pact worth more than $300 mln Aug 22 2001 05:03 AM PDT
British Airways to test fly a Concorde Tuesday Jul 16 2001 04:59 AM PDT
British Airways to test fly a Concorde Tuesday Jul 16 2001 04:59 AM PDT
Isis to identify function of 200 genes for Celera Jul 16 2001 04:58 AM PDT
Isis to identify function of 200 genes for Celera Jul 16 2001 04:58 AM PDT
> More WIRE STORIES about this company
PROFILE |
 |
Isis Pharmaceuticals may not be as all-powerful as its namesake, but the Goddess thinks it has a good thing going with its flagship product, Vitravene. Based on antisense technology, which inhibits the production of disease-causing proteins in human cells, the drug treats cytomegalovirus retinitis, a cause of blindness in AIDS patients. Partner Novartis Ophthalmics (once part of CIBA Vision, also a unit of Novartis) has worldwide marketing rights for the drug. Isis has other antisense-based drugs in various stages of development; disease targets include Crohn's disease, psoriasis, rheumatoid arthritis, hepatitis C, and cancer. Partners Novartis and Elan each own about 5% of the firm.
COMPETITION |
 |
Alcon Laboratories, Inc. (dossier)
Allergan Specialty Therapeutics, Inc. (ASTI)
Ribozyme Pharmaceuticals, Inc. (RZYM)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 37.30
1-Yr. Sales Growth: 10.0%
Employees: 303
Revenue per employee: $123,102.31
KEY PEOPLE |
 |
Stanley T. Crooke
CEO
B. Lynne Parshall
CFO
CONTACT INFO |
 |
2292 Faraday Ave.
Carlsbad, CA 92008
US
Phone: 760-931-9200
Fax: 760-931-9639
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |